Literature DB >> 19945875

The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.

Paul A Barsanti1, Weibo Wang, Zhi-Jie Ni, David Duhl, Nathan Brammeier, Eric Martin, Dirksen Bussiere, Annette O Walter.   

Abstract

A series of tetrahydro-beta-carbolines were identified by HTS as inhibitors of the kinesin Eg5. Molecular modeling and medicinal chemistry techniques were employed to explore the SAR for this series with a focus of removing potential metabolic liabilities and improving cellular potency. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945875     DOI: 10.1016/j.bmcl.2009.11.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  3D-QSAR studies of dihydropyrazole and dihydropyrrole derivatives as inhibitors of human mitotic kinesin Eg5 based on molecular docking.

Authors:  Xingyan Luo; Mao Shu; Yuanqiang Wang; Jin Liu; Wenjuan Yang; Zhihua Lin
Journal:  Molecules       Date:  2012-02-17       Impact factor: 4.411

Review 2.  Kinesins and cancer.

Authors:  Oliver Rath; Frank Kozielski
Journal:  Nat Rev Cancer       Date:  2012-07-24       Impact factor: 60.716

3.  Discovery of Novel Allosteric Eg5 Inhibitors Through Structure-Based Virtual Screening.

Authors:  Wei Zhang; Ling Zhai; Wenyan Lu; Rebecca J Boohaker; Indira Padmalayam; Yonghe Li
Journal:  Chem Biol Drug Des       Date:  2016-03-06       Impact factor: 2.817

4.  Design, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agents.

Authors:  Li Shen; Eun-Jung Park; Tamara P Kondratyuk; Daniela Guendisch; Laura Marler; John M Pezzuto; Anthony D Wright; Dianqing Sun
Journal:  Bioorg Med Chem       Date:  2011-09-16       Impact factor: 3.641

5.  A β-carboline derivative-based nickel(ii) complex as a potential antitumor agent: synthesis, characterization, and cytotoxicity.

Authors:  Jing-Mei Yang; Yan-Hong Zhu; Sheng Chen; Xing Lu; Yi-Ming Wu; Feng-E Ma; Liang-Ping Li; Yang Yang; Zhen-Hao Shi; Kun-Yuan Huang; Xue Hong; Ping Jiang; Yan Peng
Journal:  Medchemcomm       Date:  2017-11-24       Impact factor: 3.597

6.  Optical Control of Mitosis with a Photoswitchable Eg5 Inhibitor.

Authors:  Anna C Impastato; Andrej Shemet; Nynke A Vepřek; Gadiel Saper; Henry Hess; Lu Rao; Arne Gennerich; Dirk Trauner
Journal:  Angew Chem Int Ed Engl       Date:  2022-01-14       Impact factor: 16.823

7.  A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.

Authors:  Liang Sun; Jiaju Lu; Zhihong Niu; Kejia Ding; Dongbin Bi; Shuai Liu; Jiamei Li; Fei Wu; Hui Zhang; Zuohui Zhao; Sentai Ding
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

Review 8.  β-Carboline-based molecular hybrids as anticancer agents: a brief sketch.

Authors:  Jay Prakash Soni; Yogesh Yeole; Nagula Shankaraiah
Journal:  RSC Med Chem       Date:  2021-03-24

9.  Optimized S-trityl-L-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft models.

Authors:  James A D Good; Fang Wang; Oliver Rath; Hung Yi Kristal Kaan; Sandeep K Talapatra; Dawid Podgórski; Simon P MacKay; Frank Kozielski
Journal:  J Med Chem       Date:  2013-02-27       Impact factor: 7.446

Review 10.  Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy.

Authors:  Stephanie M Myers; Ian Collins
Journal:  Future Med Chem       Date:  2016-03-15       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.